Burden of Sodium Abnormalities in Patients Hospitalized for Heart Failure

Congestive Heart Failure

Volumn 17, Issue 1, 2011, Pages 1-7

  Shorr, Andrew F ^a   Tabak, Ying P ^b   Johannes, Richard S ^b,c   Gupta, Vikas ^b   Saltzberg, Mitchell T ^d   Costanzo, Maria R ^e  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b CareFusion   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Christiana Healthcare System   (United States)

^e Midwest Heart Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; ECONOMIC ASPECT; HOSPITAL COST; HOSPITALIZATION; HUMAN; HYPERNATREMIA; HYPONATREMIA; LENGTH OF STAY; MORTALITY; PRIORITY JOURNAL; SODIUM BLOOD LEVEL;

AGED; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; HYPERNATREMIA; HYPONATREMIA; LENGTH OF STAY; MALE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SODIUM; UNITED STATES;

EID: 79251631938     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2010.00206.x     Document Type: Article

References (36)

1. Curtis LH, Whellan DJ, Hammill BG, et al. Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med. 2008;168(4):418-424.
2. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008;52(6):428-434.
3. Hugli O, Braun JE, Kim S, et al. United States emergency department visits for acute decompensated heart failure, 1992 to 2001. Am J Cardiol. 2005;96(11):1537-1542.
4. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347(18):1397-1402.
5. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):e21-e181.
6. Klein L, O'Connor CM, Leimberger JD, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation. 2005;111(19):2454-2460.
7. Rossi J, Bayram M, Udelson JE, et al. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial. Acute Card Care. 2007;9(2):82-86.
8. Gheorghiade M, Rossi JS, Cotts W, et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med. 2007;167(18):1998-2005.
9. Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007;28(8):980-988.
10. Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am J Med. 2006;119(7 suppl 1):S30-S35.
11. Ghali JK. Hyponatraemia in heart failure: a call for redefinition. Eur Heart J. 2007;28(8):920-921.
12. Iezzoni LI, Moskowitz MA. A clinical assessment of MedisGroups. JAMA. 1988;260(21):3159-3163.
13. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243-250.
14. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128(6):3854-3862.
15. Shorr AF, Tabak YP, Killian AD, et al. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med. 2006;34(10):2588-2595.
16. Shorr AF, Tabak YP, Gupta V, et al. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care. 2006;10(3):R97.
17. Silber JH, Rosenbaum PR, Schwartz JS, et al. Evaluation of the complication rate as a measure of quality of care in coronary artery bypass graft surgery. JAMA. 1995;274(4):317-323.
18. Tabak YP, Johannes RS, Silber JH. Using automated clinical data for risk adjustment: development and validation of six disease-specific mortality predictive models for pay-for-performance. Med Care. 2007;45(8):789-805.
19. Killian AD, Gupta V, Goetz AE. Cost analysis of erythropoietic-stimulating therapy dosing in oncology inpatients. Ann Pharmacother. 2006;40(3):421-426.
20. Basu A, Rathouz PJ. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostatistics. 2005;6(1):93-109.
21. Efron B, Tibshirani R. An Introduction to the Bootstrap. London, UK: Chapman & Hall; 1993.
22. Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53(7):589-596.
23. Androne AS, Hryniewicz K, Hudaihed A, et al. Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol. 2004;93(10):1254-1259.
24. Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 2001;345(8):574-581.
25. Gheorghiade M, Gattis WA, O'Connor CM, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA. 2004;291(16):1963-1971.
26. Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol. 2006;47(1):1-8.
27. Schrier RW. Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med. 1990;113(2):155-159.
28. Castrop H, Schweda F, Mizel D, et al. Permissive role of nitric oxide in macula densa control of renin secretion. Am J Physiol Renal Physiol. 2004;286(5):F848-F857.
29. Nohria A, Hasselblad V, Stebbins A, et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol. 2008;51(13):1268-1274.
30. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356(20):2064-2072.
31. Gottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002;8(3):136-141.
32. Krumholz HM, Chen YT, Vaccarino V, et al. Correlates and impact on outcomes of worsening renal function in patients ≥65years of age with heart failure. Am J Cardiol. 2000;85(9):1110-1113.
33. Fonarow GC, Adams KF Jr, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293(5):572-580.
34. Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004;147(2):331-338.
35. Verbalis JG. Hyponatremia: epidemiology, pathophysiology, and therapy. Curr Opin Nephrol Hypertens. 1993;2(4):636-652.
36. Rusinaru D, Buiciuc O, Leborgne L, et al. Relation of serum sodium level to long-term outcome after a first hospitalization for heart failure with preserved ejection fraction. Am J Cardiol. 2009;103(3):405-410.